Currently, the only oral GLP-1 approved for diabetes remains Rybelsus (oral semaglutide by Novo Nordisk)
The semaglutide to tirzepatide conversion chart and tirzepatide to semaglutide conversion chart articles provide dose equivalency guidance that pairs perfectly with plotter visualization
Key Takeaways AOD 9604 is a growth hormone fragment, not HGH: it is the 176-191 fragment studied for fat metabolism, without the broader growth effects of full growth hormone
Potential Future Applications As research continues, the list of potential applications for BPC-157 is growing
A peptide credited with somnogenic, analgesic, anti-stress, endocrine, and anti-withdrawal actions, with no receptor and no established pathway linking any of them, is a peptide whose reported activity has never been localized